OncoViews
Uniting oncologists for borderless exchange
Uniting healthcare professionals for
borderless exchange in oncology
CME-certified
All roundtable sessions accredited
UPCOMING
Join us forour roundtable in||latest advances in||your questions on||new therapies for||practice changes in||your patient cases in
Gynecological Cancers
Apostolos Sarivalasis
Lausanne University Hospital, Switzerland
Ilaria Colombo
oncology institute of southern switzerland
2 CME Points
SGMO • SSOM • SSMO
Join our host, Apostolos Sarivalasis, for an exciting roundtable on the latest breakthroughs in gynecological cancers, specifically cervical, ovarian, and endometrial cancers. This interdisciplinary roundtable brings together leading experts to share and discuss cutting-edge insights from the ESMO 2024 Congress, providing a deep dive into the newest therapeutic strategies. Don’t miss this chance to expand your knowledge, ask your questions, and discover key developments shaping the future of gynecological cancer treatment.
ADD THIS TO YOUR CALENDAR
Google Calendar (Online)
Outlook Calendar (Open Downloaded File)-
Outlook On Microsoft Office 365 (Online) -
Outlook On The Web (Online) 
Apple Offline Calendar / iCal
When: 5:30 PM - 7:00 PM (CEST)
Register here
Do You Have An Account Already?
No need to sign up again: as a verified OncoViewer, you will have access to all our upcoming sessions. Simply login to participate in this session.
First Time On OncoViews?
COMING SOON
- Google Calendar (Online)
- Outlook Calendar (Open Downloaded File)
- Outlook On Microsoft Office 365 (Online)
- Outlook On The Web (Online)
- Apple Offline Calendar / iCal
When: 5:30 PM - 7:00 PM (CEST)
- Google Calendar (Online)
- Outlook Calendar (Open Downloaded File)
- Outlook On Microsoft Office 365 (Online)
- Outlook On The Web (Online)
- Apple Offline Calendar / iCal
When: 5:00 PM - 6:30 PM (CET)
- Google Calendar (Online)
- Outlook Calendar (Open Downloaded File)
- Outlook On Microsoft Office 365 (Online)
- Outlook On The Web (Online)
- Apple Offline Calendar / iCal
When: 5:00 PM - 6:30 PM (CET)
- Google Calendar (Online)
- Outlook Calendar (Open Downloaded File)
- Outlook On Microsoft Office 365 (Online)
- Outlook On The Web (Online)
- Apple Offline Calendar / iCal
When: 5:00 PM - 6:30 PM (CET)
LATEST
Roundtable Sessions
Chronic lymphocytic leukemia
1 h 30 min
Breast Cancer (ASCO 2024)
1 h 34 min
GI Cancers (ASCO 2024)
1 h 31 min
Lung Cancer (ASCO 2024)
1 h 32 min
GU Cancers (ASCO 2024)
1 h 36 min
DLBCL Debate: Bispecifics VS. CAR-T
1 h 32 min
HER2 in Lung, GYNE & GI Cancers
1 h 34 min
Prostate & Urothelial Cancer
1 h 32 min
Biomarkers in GI & Lung
1 h 45 min
Early NSCLC
1 h 30 min
Articles
Swiss Approval
Swissmedic Approves Alectinib Monotherapy For ALK-Positive NSCLC
Ilaria Colombo
HER2-Expressing Gynecological Cancers: Catching Up on Targeted Approaches
PEAK Medicals
Our New Partnership with Universimed and Leading Opinions
EMA Approval
EU Recommends New Treatments for Endometrial and Urothelial Cancers
Swiss Approval
Swissmedic Approves Durvalumab for Perioperative Treatment of Resectable NSCLC
Deborah Mukherji
Metastatic Prostate Cancer: Optimization of Systemic Treatment
Swiss Approval
Swissmedic Approves New Treatments for Gastric and Biliary Cancers
Swiss Approval
Recent Advances in Cancer Treatment: New Approvals in Prostate, Solid Tumors, and Colorectal Cancer
EMA Approval
Capivasertib Plus Fulvestrant Gains EU Approval for Advanced Breast Cancer
FDA Approval